Australia markets closed

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7700-0.0700 (-3.80%)
At close: 04:00PM EDT
1.7800 +0.01 (+0.56%)
After hours: 06:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 665.15M
Enterprise value 415.81M
Trailing P/E 3.74
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)187.36
Price/book (mrq)2.30
Enterprise value/revenue 180.01
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3-38.87%
S&P500 52-week change 326.36%
52-week high 33.7300
52-week low 30.9200
50-day moving average 32.0024
200-day moving average 31.6678

Share statistics

Avg vol (3-month) 33.94M
Avg vol (10-day) 32.25M
Shares outstanding 5361.49M
Implied shares outstanding 6361.49M
Float 8124.06M
% held by insiders 11.15%
% held by institutions 165.86%
Shares short (30 Apr 2024) 423.44M
Short ratio (30 Apr 2024) 48.63
Short % of float (30 Apr 2024) 449.10%
Short % of shares outstanding (30 Apr 2024) 49.52%
Shares short (prior month 28 Mar 2024) 421.91M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 321 May 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,011.77%

Management effectiveness

Return on assets (ttm)-40.08%
Return on equity (ttm)-102.72%

Income statement

Revenue (ttm)2.31M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)4,608.30%
Gross profit (ttm)N/A
EBITDA -185.36M
Net income avi to common (ttm)-193.58M
Diluted EPS (ttm)-0.8300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)355.6M
Total cash per share (mrq)1.44
Total debt (mrq)106.24M
Total debt/equity (mrq)36.78%
Current ratio (mrq)15.58
Book value per share (mrq)1.17

Cash flow statement

Operating cash flow (ttm)-185.41M
Levered free cash flow (ttm)-111.15M